Trials / Completed
CompletedNCT04168567
The Impact of Body Mass Index on the Endometrial Microbiome in IVF Treatments. Tampere Infertility Microbiome Project (TIMP).
A Protocol for a Prospective Study to Compare the Endometrial Microbiome in Patients With Body Mass Index Over 30 kg/m² Versus Under 25 kg/m².
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 91 (actual)
- Sponsor
- Tampere University Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
This study project is an observational trial involving 90 patients suffering from male type infertility. The patients are divided in two groups (45 patients per group) based on their body mass index (BMI).
Detailed description
This study (Tampere Infertility Microbiome Project, TIMP) aims to clarify the differences in the microbiome variety between obese and normal-weight patients. The first group will consist of patients with the body mass index (BMI) over 30 kg/m², while the second group will include patients with a healthy weight BMI under 25. The samples will be collected at the time of embryo transfer and analyzed in a laboratory specialing in next-generation sequencing (NGS) techniques.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Microbiome analysis | Samples from TIMP microbiome project will be analyzed with NGS techniques. |
Timeline
- Start date
- 2020-08-14
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2019-11-19
- Last updated
- 2025-06-25
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT04168567. Inclusion in this directory is not an endorsement.